Moreover new insights into the biology of the prostate and prostate cancer are provided, indicating that the IGF axis exerts different functions in malignant and non-malignant cells, a finding that might help to better understand and avoid some side effects of IGF1R targeting agents. Here, IGF1 is linked to prostate carcinoma.